Gilead Sciences shares are trading higher after Raymond James upgraded the stock from Market Perform to Outperform.
Portfolio Pulse from Benzinga Newsdesk
Gilead Sciences shares are trading higher following an upgrade from Raymond James, which raised the stock rating from Market Perform to Outperform.
July 08, 2024 | 11:16 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Gilead Sciences shares are trading higher after Raymond James upgraded the stock from Market Perform to Outperform.
The upgrade from a reputable analyst firm like Raymond James is likely to boost investor confidence and drive short-term buying activity, leading to a rise in Gilead Sciences' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100